Overview Fundamentals API Earnings EOD API Sample Code Pricing

Taysha Gene Therapies Inc (TSHA NASDAQ) stock market data APIs

$1.25 -0.12(-8.8%) as of November 6, 2024
Price chart is built with Anychart

Taysha Gene Therapies, Inc., a gene therapy company, focuses on developing and commercializing adeno-associated virus-based gene therapies for the treatment of monogenic diseases of the central nervous system. It primarily develops TSHA-120 for the treatment of giant axonal neuropathy; TSHA-102 for the treatment of Rett syndrome; TSHA-121 for the treatment of CLN7 disease; TSHA-118 for the treatment of CLN1 disease; TSHA-105 for the treatment of for SLC13A5 deficiency; TSHA-113 for the treatment of tauopathies; TSHA-106 for the treatment of angelman syndrome; TSHA-114 for the treatment of fragile X syndrome; and TSHA-101 for the treatment of GM2 gangliosidosis. Taysha Gene Therapies, Inc. has a strategic partnership with The University of Texas Southwestern Medical Center. Taysha Gene Therapies, Inc. was incorporated in 2019 and is headquartered in Dallas, Texas.

Taysha Gene Therapies Inc Financial Data Overview

1.37
1.25
-
1.43
1.25
1.19-4.32
281 M
205 M
12 873 K
0.378
Our easy-to-use no-coding solutions help you get the data effortlessly:

No long-term obligations. The minimum period is one month only. No wait. You get an API key with instructions in a few seconds right after subscription.

General: {
Code: 'TSHA',
Type: 'Common Stock',
Name: 'Taysha Gene Therapies Inc',
Exchange: 'NASDAQ',
CurrencyCode: 'USD',
CurrencyName: 'US Dollar',
CurrencySymbol: '$',
CountryName: 'USA',
CountryISO: 'US',
OpenFigi: 'BBG00TJXFDP1',
ISIN: NULL,
CUSIP: NULL,
CIK: '1806310',
EmployerIdNumber: NULL,
FiscalYearEnd: 'December',
IPODate: '2020-09-24',
InternationalDomestic: NULL,
Sector: 'Healthcare',
Industry: 'Biotechnology',
HomeCategory: NULL,
IsDelisted: false,
}

Taysha Gene Therapies Inc Fundamental Data is available in our Financial Data APIs

  • Net Revenue 12 873 K
  • EBITDA -75 716 000
  • Earnings Per Share -0.49
  • Income Statements
  • Balance Sheets
  • Cash flows
Get sample
of Fundamental API Data

Get Taysha Gene Therapies Inc Earnings via APIs

  • Latest Release 2024-11-12
  • EPS/Forecast -0.09

Get Taysha Gene Therapies Inc End-of-day Data via APIs

  • End of Day, Intraday and Live APIs
  • Splits
  • Dividends
Do you have any questions?
support@eodhistoricaldata.com